FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-Louis Vildé

Research Profile

Disorders

Concepts & Ideas

Procedures

Phenomena

Recurrence

Chemicals & Drugs

Living Beings

HIV-1

Co-author Network

Publications

TOP 3
L Cibrelus; V Nöel; J Emmanuelli; Guillaume Breton; Pascale Longuet; B Rigolli; Catherine Leport; Jean-Louis Vildé
[Management of 90 patients presenting with suspected severe acute respiratory syndrome. Experience of a collaboration between epidemiologists and clinicians facing an emerging infectious disease health alert].
Zohra Berki-Benhaddad; Jean-Luc Ecobichon; France Mentré; Annie Capillon; Agnès Certain; Catherine Secondi; Anne Gervais; Pascale Longuet; Jean-Louis Vildé; Catherine Leport
[Adherence intervention for HIV-infected patients receiving antiretroviral treatment. Implementation and initial assessment].
Valérie Journot; Geneviève Chene; Nathalie de Castro; Corinne Rancinan; Jill-Patrice Cassuto; Christian Allard; Jean-Louis Vildé; Alain Sobel; Michel Garré; Jean-Michel Molina
Use of efavirenz is not associated with a higher risk of depressive disorders: a substudy of the randomized clinical trial ALIZE-ANRS 099.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-Louis Vildé (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: L Cibrelus; V Nöel; J Emmanuelli; Guillaume Breton; Pascale Longuet; B Rigolli; Catherine Leport; Jean-Louis Vildé
[Management of 90 patients presenting with suspected severe acute respiratory syndrome. Experience of a collaboration between epidemiologists and clinicians facing an emerging infectious disease health alert].
Médecine et maladies infectieuses 2007;37 Suppl 3():S242-50.
2006: Zohra Berki-Benhaddad; Jean-Luc Ecobichon; France Mentré; Annie Capillon; Agnès Certain; Catherine Secondi; Anne Gervais; Pascale Longuet; Jean-Louis Vildé; Catherine Leport
[Adherence intervention for HIV-infected patients receiving antiretroviral treatment. Implementation and initial assessment].
Presse médicale (Paris, France : 1983) 2006;35(9 Pt 1):1241-8.
2006: Valérie Journot; Geneviève Chene; Nathalie de Castro; Corinne Rancinan; Jill-Patrice Cassuto; Christian Allard; Jean-Louis Vildé; Alain Sobel; Michel Garré; Jean-Michel Molina
Use of efavirenz is not associated with a higher risk of depressive disorders: a substudy of the randomized clinical trial ALIZE-ANRS 099.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(12):1790-9.
2005: Agnès Meybeck; Guillaume Breton; Naji Aoun; homa adle-biassette; Simon Jacobelli; Jean-Louis Vildé; Patrick Yeni
Upper respiratory tract involvement in the course of diffuse infiltrative lymphocytosis syndrome in HIV-1-infected patients: report of 2 cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(2):e22-6.
2005: J Autier; C Picard-Dahan; Eduardo Marinho; Maggy Grossin; Patrick Yeni; C Leport; Jean-Louis Vildé; Béatrice Crickx; Vincent Descamps
Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study.
The British journal of dermatology 2005;152(5):1026-9.
2005: Stéphanie Leclerc; Olivier Brunschwig; Zhora Berki-Benhaddad; Dominique Soyris; Christian Grataud; Guillaume Breton; Catherine Leport; Jean-Louis Vildé
[Antiretroviral therapy for HIV-infected patients with schizophrenia. Coordinated multidisciplinary management (7 cases)].
Presse médicale (Paris, France : 1983) 2005;34(6):431-7.
2005: Guillaume Breton; Stéphanie Leclerc; Pascale Longuet; Catherine Leport; Jean-Louis Vildé; Jean-Pierre Laissy
[Myocardial localisation of tuberculosis: the diagnostic value of cardiac MRI].
Presse médicale (Paris, France : 1983) 2005;34(4):293-6.
2005: Xavier Duval; Diane Descamps; Guillaume Breton; Sophie Darmon; Jean-Luc Ecobichon; Séverine Delarue; Gilles Peytavin; Catherine Leport; Jean-Louis Vildé; Françoise Brun-Vézinet
Evolution of protease and reverse transcriptase inhibitor resistance-associated mutations in HIV-1-infected protease inhibitor-treated patients with persistent low viraemia.
Antiviral therapy 2005;10(1):197-9.
2004: Guillaume Breton; Xavier Duval; Candice Estellat; Xavier Poaletti; Daniel Bonnet; David Mvondo Mvondo; Pascale Longuet; Catherine Leport; Jean-Louis Vildé
Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(11):1709-12.
2004: Charlotte Lewden; Hélène Jacqmin-Gadda; Jean-Louis Vildé; François Bricaire; Anne Waldner-Combernoux; thierry may; Lise Cuzin; Jean-Marie Lang; Catherine Leport; Geneviève Chêne
An example of nonrandom missing data for hepatitis C virus status in a prognostic study among HIV-infected patients.
HIV clinical trials 2004;5(4):224-31.
2004: Xavier Duval; Gilles Peytavin; I Albert; S Bénoliel; Jean-Luc Ecobichon; Françoise Brun-Vézinet; France Mentré; Catherine Leport; Jean-Louis Vildé
Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients.
HIV medicine 2004;5(4):307-13.
2004: Guillaume Breton; M A Bouldouyre; Anne Gervais; Xavier Duval; Pascale Longuet; Catherine Leport; Jean-Louis Vildé
Failure of valacyclovir for herpes zoster in a moderately immunocompromised HIV-infected patient.
AIDS patient care and STDs 2004;18(5):255-7.
2003: Guillaume Breton; Xavier Duval; Anne Gervais; Pascale Longuet; Catherine Leport; Jean-Louis Vildé
Retroviral rebound syndrome with meningoencephalitis after cessation of antiretroviral therapy.
The American journal of medicine 2003;114(9):769-70.
2003: homa adle-biassette; Michel Huerre; Guillaume Breton; raymond ruimy; Amélie Carbonnelle; Didier Trophilme; Mokrane Yacoub; Bernard Régnier; Patrick Yéni; Jean-Louis Vildé; Dominique Hénin
[Non tuberculous mycobacterial diseases].
Annales de pathologie 2003;23(3):216-35.
2003: Jean-Louis Vildé
[Tuberculosis and non tuberculous mycobacterial diseases].
Annales de pathologie 2003;23(3):205.
2003: P Brazille; Nathalie Dereuddre-Bosquet; Catherine Leport; Pascal Clayette; Olivier Boyer; Jean-Louis Vildé; D Dormont; Olivier Benveniste
Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.
Clinical and experimental immunology 2003;131(2):304-11.
2002: Louis Bernard; Albert Vuagnat; Gilles Peytavin; Marie-Charlotte Hallouin; Damien Bouhour; Thu Huyen Nguyen; Jean-Louis Vildé; François Bricaire; Gilles Raguin; pierre de truchis; David Ghez; Michel Duong; Christian Perronne
Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy.
Annals of internal medicine 2002;137(8):656-9.
2002: Charlotte Lewden; François Raffi; Lise Cuzin; Valérie Cailleton; Jean-Louis Vildé; Geneviève Chêne; Clotilde Allavena; Roger Salamon; Catherine Leport
Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiprotéases Cohorte Agence Nationale de Recherches sur le SIDA EP 11 study.
The Journal of infectious diseases 2002;186(5):710-4.
2001: Olivier Benveniste; Jérôme Estaquier; Jean-Daniel Lelièvre; Jean-Louis Vildé; Jean-Claude Ameisen; Catherine Leport
Possible mechanism of toxicity of zidovudine by induction of apoptosis of CD4+ and CD8+ T-cells in vivo.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2001;20(12):896-7.
2001: N Fidouh-Houhou; Xavier Duval; F Bissuel; V Bourbonneux; Philippe Flandre; Jean-Luc Ecobichon; M Colin Jordan; Jean-Louis Vildé; Françoise Brun-Vézinet; Catherine Leport
Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(8):1406-11.
2001: F Maccari; Vincent Descamps; Xavier Duval; Maggy Grossin; Jean-Louis Vildé; Béatrice Crickx
[Skin manifestations of immune restoration syndrome in treated tuberculosis].
Annales de dermatologie et de vénéréologie 2001;128(10 Pt 1):1028-30.
2001: Xavier Duval; S Djendli; Vincent Le Moing; Pascale Longuet; B Barry; Catherine Leport; Jean-Louis Vildé
Recurrent Staphylococcus aureus extracerebral infections complicating hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease).
The American journal of medicine 2001;110(8):671-2.
2001: Xavier Duval; S Trad; Vincent Le Moing; Pascale Longuet; Catherine Leport; Jean-Louis Vildé
[Paradoxical aggravation of tuberculosis after antiretroviral therapy in HIV-infected patients].
Presse médicale (Paris, France : 1983) 2001;30(5):213-6.
2001: Xavier Duval; Vasileios Papastamopoulos; Pascale Longuet; C Benoit; Christian Perronne; Catherine Leport; Jean-Louis Vildé
Definite streptococcus bovis endocarditis: characteristics in 20 patients.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2001;7(1):3-10.
2000: Xavier Duval; Vincent Le Moing; C Longuet; Catherine Leport; Jean-Louis Vildé; Claire Lamotte; Gilles Peytavin; Robert Farinotti
Efavirenz-induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir.
Antimicrobial agents and chemotherapy 2000;44(9):2593.
2000: Olivier Benveniste; Nathalie Dereuddre-Bosquet; Pascal Clayette; Catherine Leport; Jean-Louis Vildé; D Dormont
High levels of IL-10 and determination of other cytokines and chemokines in HIV-associated haemophagocytic syndrome.
Clinical and experimental immunology 2000;121(2):320-3.
1999: Pascale Longuet; Xavier Duval; Vincent Le Moing; A Scanvic-Hameg; Catherine Leport; Jean-Louis Vildé
[Antibiotic prophylaxis in patients at high risk of nosocomial outbreak of legionellosis].
Presse médicale (Paris, France : 1983) 1999;28(32):1755-6.
1999: Xavier Duval; G Peytavin; B Fouqueray; C Leport; Jean-Louis Vildé
Renin-angiotensin system inhibition in a patient having an overdose of HIV protease inhibitor.
AIDS (London, England) 1999;13(14):1983-4.
1999: Olivier Benveniste; Pascale Longuet; Xavier Duval; Vincent Le Moing; Catherine Leport; Jean-Louis Vildé
Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(5):1180-1.
1999: Vincent Le Moing; Flore Lacassin; M Delahousse; Xavier Duval; Pascale Longuet; Catherine Leport; Jean-Louis Vildé
Use of corticosteroids in glomerulonephritis related to infective endocarditis: three cases and review.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(5):1057-61.
1999: Dominique Salmon-Céron; Anne-Marie Fillet; Jean-Pierre Aboulker; Laurence Gérard; Nadhira Houhou; I Carrière; J Ostinelli; Jean-Louis Vildé; Françoise Brun-Vézinet; Catherine Leport
Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(4):901-5.
1998: J L Mainardi; Flore Lacassin; Y Guilloy; Fred W Goldstein; Catherine Leport; JF Acar; Jean-Louis Vildé
Low rate of Clostridium difficile colonization in ambulatory and hospitalized HIV-infected patients in a hospital unit: a prospective survey.
The Journal of infection 1998;37(2):108-11.
1998: Geneviève Chêne; Philippe Morlat; Catherine Leport; Richard Hafner; L Dequae; Isabelle Charreau; Jean-Pierre Aboulker; Benjamin J Luft; J Aubertin; Jean-Louis Vildé; Roger Salamon
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.
Controlled clinical trials 1998;19(3):233-48.
1998: Olivier Benveniste; Fabrice Bruneel; Jean-Pierre Bédos; Michel Wolff; G Lesèche; Catherine Leport; Jean-Louis Vildé; François Vachon; Bernard Régnier
Ruptured mycotic pulmonary artery aneurysm: an unusual complication of right-sided endocarditis.
Scandinavian journal of infectious diseases 1998;30(6):626-9.
1997: Laurence Gérard; Catherine Leport; Philippe Flandre; Nadhira Houhou; Dominique Salmon-Céron; J M Pépin; C Mandet; Françoise Brun-Vézinet; Jean-Louis Vildé
Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(5):836-40.
1997: Sophie Pueyo; L Rachid Salmi; Geneviève Chêne; Catherine Leport; Philippe Morlat; L Dequae; V Grégoire; Richard Hafner; Jean-Louis Vildé; Benjamin J Luft; J Aubertin; Roger Salamon
Survival after AIDS-defining events in patients with < 200 lymphocytes CD4+ x 10(6)/L who are toxoplasmosis antibody positive. ANRS 005/ACTG 154 Trial Group.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;14(5):459-64.
1997: Xavier Anglaret; François Dabis; J Batungwanayo; Christian Perronne; H Taelman; Dominique Bonard; F Sylla-Koko; Valériane Leroy; Philippe Van de Perre; Jean-Louis Vildé; R Salamon
[Primary chemoprevention of tuberculosis in HIV-infected patients in non-industrialized countries].
Santé (Montrouge, France) 1997;7(2):89-94.
1997: F Rousseau; Sophie Pueyo; Philippe Morlat; Richard Hafner; G Chène; Catherine Leport; Benjamin J Luft; J Miro; J Aubertin; Roger Salamon; Jean-Louis Vildé
Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(3):396-402.
1997: Flore Lacassin; L Loussert-Ajaka; Catherine Leport; Françoise Brun-Vézinet; Jean-Louis Vildé; F Simon
Rapid fatal evolution in two cases of infection due to HIV-1 uncommon subtypes in France.
AIDS (London, England) 1997;11(2):267-8.
1997: S Barete; F Bissuel; Pascale Longuet; M A Pocidalo; Catherine Leport; Jean-Louis Vildé
[Agranulocytosis during a treatment with terbinafine].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1997;18(3):258-9.
1996: Francis Derouin; Catherine Leport; Sophie Pueyo; Philippe Morlat; B Letrillart; Geneviève Chêne; J L Ecobichon; Benjamin J Luft; J Aubertin; Richard Hafner; Jean-Louis Vildé; Roger Salamon
Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.
AIDS (London, England) 1996;10(13):1521-7.
1996: Catherine Leport; P Ambroise-Thomas; C Bazin; G Chène; F Derouin; Christine Katlama; C Mayaud; H Pelloux; F Raffi; Jean-Louis Vildé
[Risk factors of the occurrence of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention. Proposals of the Toxoplasmosis and other protozoan infections Group. Coordinated action N.5 - 1996 February].
Presse médicale (Paris, France : 1983) 1996;25(11):519-20.
1996: Catherine Leport; P Ambroise-Thomas; C Bazin; G Chène; F Derouin; Christine Katlama; C Mayaud; H Pelloux; F Raffi; Jean-Louis Vildé
[Risk factors of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention].
Annales de médecine interne 1996;147(5):331-2.
1996: Catherine Leport; Geneviève Chêne; Philippe Morlat; Benjamin J Luft; F Rousseau; Sophie Pueyo; Richard Hafner; J Miro; J Aubertin; Roger Salamon; Jean-Louis Vildé
Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group.
The Journal of infectious diseases 1996;173(1):91-7.
1995: Dominique Salmon-Ceron; A Fontbonne; J Saba; T May; F Raffi; C Chidiac; O Patey; Jean-Pierre Aboulker; David H Schwartz; Jean-Louis Vildé
Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group.
The Journal of infectious diseases 1995;172(3):656-64.
1995: Xavier Duval; M C Paty; Pascale Longuet; Flore Lacassin; Christian Perronne; Catherine Leport; Jean-Louis Vildé
[Pneumopathies caused by Streptococcus pneumoniae in 27 HIV infected patients].
Presse médicale (Paris, France : 1983) 1995;24(15):715-8.
1995: Flore Lacassin; J C Mino; C Benoit; C Perronne; Catherine Leport; Jean-Louis Vildé
[A case of avian salmonellosis].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1995;16(1):77-8.
1994: O Lortholary; F Lisovoski; J M Bréchot; Pascale Longuet; Christian Perronne; Catherine Leport; Jean-Louis Vildé
Myelitis due to Toxoplasma gondii in a patient with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(6):1167-8.
1994: Xavier Anglaret; J Saba; Christian Perronne; Flore Lacassin; Pascale Longuet; Catherine Leport; Jean-Louis Vildé
Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis.
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1994;75(5):334-40.
1994: Christian Perronne; J Saba; Z Behloul; Dominique Salmon-Céron; Catherine Leport; Jean-Louis Vildé; M F Kahn
Pyogenic and tuberculous spondylodiskitis (vertebral osteomyelitis) in 80 adult patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1994;19(4):746-50.
1994: H Mentec; Catherine Leport; J Leport; C Marche; M Harzic; Jean-Louis Vildé
Cytomegalovirus colitis in HIV-1-infected patients: a prospective research in 55 patients.
AIDS (London, England) 1994;8(4):461-7.
1994: G Walckenaer; Catherine Leport; Pascale Longuet; Christian Perronne; Flore Lacassin; Jean-Louis Vildé
[Recurrence of cerebral toxoplasmosis in 15 AIDS patients].
Annales de médecine interne 1994;145(3):181-4.
1993: F Rousseau; C Perronne; P Dény; R Mestassi; H Laraki; C Marche; Catherine Leport; Jean-Louis Vildé
Prolonged and fatal disseminated cytomegalovirus infection in an immunocompetent woman.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(12):938-40.
1993: Pascale Longuet; E Vallée; M Michel; Christian Perronne; M Janvier; Catherine Leport; Jean-Louis Vildé
[Vancomycin in meningitis caused by penicillin G resistant Streptococcus pneumoniae].
Presse médicale (Paris, France : 1983) 1993;22(36):1818-9.
1993: O Lortholary; C Perronne; J Leport; Catherine Leport; Jean-Louis Vildé
Primary cytomegalovirus infection associated with the onset of ulcerative colitis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(7):570-2.
1993: Flore Lacassin; Pascale Longuet; Christian Perronne; Catherine Leport; P Gehanno; Jean-Louis Vildé
[Infectious sinusitis in HIV infection. Clinical and therapeutic data on 20 patients].
Presse médicale (Paris, France : 1983) 1993;22(19):899-902.
1992: Dominique Salmon-Ceron; pierre de truchis; A Jaccard; Catherine Leport; D Karam-Sarkis; W Rosenbaum; Marie-Caroline Meyohas; Jean-Pierre Coulaud; Jean-Louis Vildé
[Non-typhic Salmonella bacteremias in HIV infections. Clinical and therapeutic data, and course in 68 patients].
Presse médicale (Paris, France : 1983) 1992;21(18):847-51.
1992: Christian Perronne; A Ghoubontni; Catherine Leport; Dominique Salmon-Céron; F Bricaire; Jean-Louis Vildé
Should pulmonary tuberculosis be an AIDS-defining diagnosis in patients infected with HIV?
Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1992;73(1):39-44.
1991: T Niyongabo; Catherine Leport; Jean-Louis Vildé
[Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients].
Presse médicale (Paris, France : 1983) 1991;20(34):1677-81.
1991: Catherine Leport; C Tournerie; G Raguin; J Fernandez-Martin; T Niyongabo; Jean-Louis Vildé
Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1991;10(3):191-3.
1991: J C Melchior; D Salmon; Daniel Rigaud; Catherine Leport; E Bouvet; pierre de truchis; Jean-Louis Vildé; F Vachon; Jean-Pierre Coulaud; M Apfelbaum
Resting energy expenditure is increased in stable, malnourished HIV-infected patients.
The American journal of clinical nutrition 1991;53(2):437-41.
1991: D Salmon; pierre de truchis; Catherine Leport; E Bouvet; D Karam; Marie-Caroline Meyohas; Jean-Pierre Coulaud; Jean-Louis Vildé
Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS.
The Journal of infectious diseases 1991;163(2):415-6.
1990: Christian Perronne; M Lazanas; Catherine Leport; F Simon; D Salmon; A Dallot; Jean-Louis Vildé
Varicella in patients infected with the human immunodeficiency virus.
Archives of dermatology 1990;126(8):1033-6.
1990: Christian Perronne; M Lazanas; A Bellou; Catherine Leport; P Canton; Jean-Louis Vildé
[Zona in 50 patients infected by human immunodeficiency virus. Clinical manifestations and prognostic value].
Presse médicale (Paris, France : 1983) 1990;19(16):752-4.
1990: J M Besnier; Catherine Leport; A Buré; Jean-Louis Vildé
Vancomycin-aminoglycoside combinations in therapy of endocarditis caused by Enterococcus species and Streptococcus bovis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1990;9(2):130-3.
1989: F Bricaire; B Godeau; D Salmon; D Karam; Catherine Leport; Jean-Louis Vildé
[Chronic bone infections after surgery. Treatment with the new quinolones].
Presse médicale (Paris, France : 1983) 1989;18(28):1383-6.
1988: Christian Perronne; M Zahraoui; Catherine Leport; D Salmon; B Pangon; F Bricaire; Jean-Louis Vildé
[Tuberculosis in patients infected with the human immunodeficiency virus. 30 cases].
Presse médicale (Paris, France : 1983) 1988;17(29):1479-83.
1987: Jean-Louis Vildé; J Leport
[Sexually transmitted diseases in the male homosexual].
La Revue du praticien 1987;37(15):817-22.
1986: C Perronne; B Régnier; Patrick Legrand; A Buré; J Frottier; Jean-Louis Vildé; François Vachon
[Failure of new beta-lactam antibiotics in the treatment of severe Enterobacter cloacae infections].
Presse médicale (Paris, France : 1983) 1986;15(36):1813-8.